4//SEC Filing
Graboyes Marc H 4
Accession 0001127602-12-009004
CIK 0001097264other
Filed
Feb 29, 7:00 PM ET
Accepted
Mar 1, 6:13 PM ET
Size
8.5 KB
Accession
0001127602-12-009004
Insider Transaction Report
Form 4
Graboyes Marc H
VP, General Counsel
Transactions
- Sale
Common Stock
2012-03-01$1.48/sh−9,635$14,260→ 542,028 total - Sale
Common Stock
2012-02-29$1.52/sh−9,425$14,366→ 551,663 total - Award
Common Stock
2012-02-28+222,266→ 561,088 total
Footnotes (3)
- [F1]Represents shares of common stock issued as restricted stock units ("RSUs") awarded under the Company's 2008 Equity Incentive Plan (the "Plan"). The RSUs shall vest in a series of eight (8) successive equal semi-annual installments over the four (4)-year period measured from March 18, 2012 (the "Vesting Commencement Date"), subject to Participant's Continuous Service through each such date.
- [F2]These shares are being sold pursuant to a 10b5-1 plan for Marc H. Graboyes in order to cover the withholding tax and other costs associated with such sale (i.e., wire fees, commission or interest) in connection with the vesting of restricted stock units on February 28, 2012.
- [F3]The price represents the weighted average sale price for multiple transactions reported on this line. The prices of the transactions ranged from $1.52 to $1.54. Upon request of the SEC staff, Allos Therapeutics, Inc. (the "Company") or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold at each separate price.
Documents
Issuer
ALLOS THERAPEUTICS INC
CIK 0001097264
Entity typeother
Related Parties
1- filerCIK 0001305811
Filing Metadata
- Form type
- 4
- Filed
- Feb 29, 7:00 PM ET
- Accepted
- Mar 1, 6:13 PM ET
- Size
- 8.5 KB